Global Clinical Next-Generation Sequencing market cagr 11.7%

Page 1

Clinical NextGeneration Sequencing Market

Clinical Next-Generation Sequencing Market Scope:

Industry Analysis, Market Size, Growth, Trends Till

Request Sample Report

2031

Clinical Next-Generation Sequencing Market Size and Growth

The global Clinical Next-Generation Sequencing market is predicted to reach a value of $10.6 billion by 2026, with a compound annual growth rate of 13.2%. Market drivers include increasing demand for precision medicine and advancements in NGS technology. Key players in the market include Illumina, Thermo Fisher Scientific, and Pacific Biosciences.

Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Thermo Fisher Scientific

◍ PerkinElmer

◍ Illumina

◍ Beckman Coulter

◍ GATC Biotech

◍ Qiagen

The Clinical Next-Generation Sequencing Market is highly competitive with key players like Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech, and Qiagen dominating the space. These companies provide NGS solutions for various clinical applications, contributing to market growth. Sales revenue figures: Illumina ($3.54B), Thermo Fisher Scientific ($34.1B), Qiagen ($1.53B).

Request Sample Report

Market Segmentation

By Application

◍ Hospitals and Clinics

◍ Biopharma Companies

◍ Academic and Research Organizations

◍ Others

By Product

◍ Targeted Sequencing

◍ Exome Sequencing

◍ Others

Request Sample Report

Market Growth

Request Sample Report

$ X Billion USD

THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.